lineweaver–burk plot (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
lineweaver–burk plot
Lineweaver–Burk Plot, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lineweaver-burk+plot/lineweaver+burk+plot/pm40542046-71-2-10
Average 90 stars, based on 1 article reviews
Lineweaver–Burk Plot, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/lineweaver-burk+plot/lineweaver+burk+plot/pm40542046-71-2-10
Average 90 stars, based on 1 article reviews
lineweaver–burk plot - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Construct:Article Title: Exploration of morpholine-thiophene hybrid thiosemicarbazones for the treatment of ureolytic bacterial infections via targeting urease enzyme: Synthesis, biochemical screening and computational analysis Article Snippet: Afterwards, the data was plotted to obtain the Lineweaver-Burk plot by using Article Title: Inhibition of human and rat placental 3β-hydroxysteroid dehydrogenase/Δ 5,4 -isomerase activities by insecticides and fungicides: Mode action by docking analysis. Article Snippet: Many insecticides and fungicides are endocrine-disrupting compounds, which possibly interfere with the placental endocrine system.. In the placenta, 3β-hydroxysteroid dehydrogenase/Δ5,4-isomerase type 1 (HSD3B1) is the major steroidogenic enzyme, which makes progesterone from pregnenolone to support the placental stability.. In this study, we screened 12 classes of insecticides and fungicides to inhibit placental HSD3B1 activity and compared them to the rat homolog type 4 (HSD3B4) isoform. Article Title: Amplex red assay, a standardized in vitro protocol to quantify the efficacy of autotaxin inhibitors. Article Snippet: Stylianaki et al., STAR Protocols 6, 103721 June 20, 2025 a 2025 The Autotaxin (ATX), a secreted lysophospholipase D responsible for the extracellular production of the bioactive phospholipid lysophosphatidic acid (LPA), is a therapeutic target in idiopathic pulmonary fibrosis and pancreatic cancer, among other disorders, promoting the synthesis of novel ATX inhibitors.. Here, we present a protocol for detecting and characterizing ATX inhibitors using a fluorometry-based microplate assay.. We describe steps for a first screening of compounds, half-maximal inhibitory concentration (IC50) quantification of initial hits, screening for false positives, and identification of the hits’ mode of inhibition. Article Title: Synthesis, characterization, in vitro cholinesterase and hRBCs hemolysis assay and computational evaluation of novel 2,3,4,5-tetrahydrobenzothiazepine appended α-aminophosphonates. Article Snippet: A series of novel 2,3,4,5-tetrahydrobenzothiazepine appended α-aminophosphonate derivatives were synthesized by subjecting 2,3-dihydrobenzothiazepine to Pudovik reaction using diethyl phosphite.. Tested derivatives exhibited better AChE inhibition (0.86–12.85 μM) when compared to BuChE (3.13–19.36 μM).. Derivative 5f (IC50 = 0.86 ± 0.08 μM), 5g (IC50 = 1.05 ± 0.06 μM) and 5d (IC50 = 1.64 ± 0.06 μM) exhibited higher AChE inhibitory activity as compared to standard drug galantamine (IC50 = 2.15 ± 0.05 μM). Article Title: Lipase activity inhibited by aloenin A: Glycoside from Aloe vera (L.) Burm. f.-In vitro and molecular docking studies. Article Snippet: Funding information Indian Council of Medical Research Abstract Obesity is taking over many parts of the world and has been identified as the second leading cause of preventable death, with a dramatic increase in prevalence over the last two decades.. Pancreatic lipase is a lipid-digesting enzyme that plays an important role in fat metabolism.. Inhibiting pancreatic lipase is an attractive target for obesity treatment. Article Title: Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia. Article Snippet: The development of XOD/URAT1 dual target inhibitors has emerged as a promising therapeutic strategy for the management of hyperuricemia.. Here, through virtual screening, we have identified digallic acid as a novel dual target inhibitor of XOD/URAT1 and subsequently evaluated its pharmacological properties, pharmacokinetics, and toxicities.. Digallic acid inhibited URAT1 with an IC50 of 5.34 ± 0.65 μM, which is less potent than benzbromarone (2.01 ± 0.36 μM) but more potent than lesinurad (10.36 ± 1.23 μM). Article Title: Evaluation of N -alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors. Article Snippet: Rate vs concentration was fitted to a Lineweaver-Burk plot using Article Title: Amplex red assay, a standardized in vitro protocol to quantify the efficacy of autotaxin inhibitors Article Snippet: Concentration Assay:Article Title: Exploration of morpholine-thiophene hybrid thiosemicarbazones for the treatment of ureolytic bacterial infections via targeting urease enzyme: Synthesis, biochemical screening and computational analysis Article Snippet: Afterwards, the data was plotted to obtain the Lineweaver-Burk plot by using Article Title: Inhibition of human and rat placental 3β-hydroxysteroid dehydrogenase/Δ 5,4 -isomerase activities by insecticides and fungicides: Mode action by docking analysis. Article Snippet: Many insecticides and fungicides are endocrine-disrupting compounds, which possibly interfere with the placental endocrine system.. In the placenta, 3β-hydroxysteroid dehydrogenase/Δ5,4-isomerase type 1 (HSD3B1) is the major steroidogenic enzyme, which makes progesterone from pregnenolone to support the placental stability.. In this study, we screened 12 classes of insecticides and fungicides to inhibit placental HSD3B1 activity and compared them to the rat homolog type 4 (HSD3B4) isoform. Article Title: Amplex red assay, a standardized in vitro protocol to quantify the efficacy of autotaxin inhibitors. Article Snippet: Stylianaki et al., STAR Protocols 6, 103721 June 20, 2025 a 2025 The Autotaxin (ATX), a secreted lysophospholipase D responsible for the extracellular production of the bioactive phospholipid lysophosphatidic acid (LPA), is a therapeutic target in idiopathic pulmonary fibrosis and pancreatic cancer, among other disorders, promoting the synthesis of novel ATX inhibitors.. Here, we present a protocol for detecting and characterizing ATX inhibitors using a fluorometry-based microplate assay.. We describe steps for a first screening of compounds, half-maximal inhibitory concentration (IC50) quantification of initial hits, screening for false positives, and identification of the hits’ mode of inhibition. Article Title: Synthesis, characterization, in vitro cholinesterase and hRBCs hemolysis assay and computational evaluation of novel 2,3,4,5-tetrahydrobenzothiazepine appended α-aminophosphonates. Article Snippet: A series of novel 2,3,4,5-tetrahydrobenzothiazepine appended α-aminophosphonate derivatives were synthesized by subjecting 2,3-dihydrobenzothiazepine to Pudovik reaction using diethyl phosphite.. Tested derivatives exhibited better AChE inhibition (0.86–12.85 μM) when compared to BuChE (3.13–19.36 μM).. Derivative 5f (IC50 = 0.86 ± 0.08 μM), 5g (IC50 = 1.05 ± 0.06 μM) and 5d (IC50 = 1.64 ± 0.06 μM) exhibited higher AChE inhibitory activity as compared to standard drug galantamine (IC50 = 2.15 ± 0.05 μM). Article Title: Lipase activity inhibited by aloenin A: Glycoside from Aloe vera (L.) Burm. f.-In vitro and molecular docking studies. Article Snippet: Funding information Indian Council of Medical Research Abstract Obesity is taking over many parts of the world and has been identified as the second leading cause of preventable death, with a dramatic increase in prevalence over the last two decades.. Pancreatic lipase is a lipid-digesting enzyme that plays an important role in fat metabolism.. Inhibiting pancreatic lipase is an attractive target for obesity treatment. Article Title: Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia. Article Snippet: The development of XOD/URAT1 dual target inhibitors has emerged as a promising therapeutic strategy for the management of hyperuricemia.. Here, through virtual screening, we have identified digallic acid as a novel dual target inhibitor of XOD/URAT1 and subsequently evaluated its pharmacological properties, pharmacokinetics, and toxicities.. Digallic acid inhibited URAT1 with an IC50 of 5.34 ± 0.65 μM, which is less potent than benzbromarone (2.01 ± 0.36 μM) but more potent than lesinurad (10.36 ± 1.23 μM). Article Title: Evaluation of N -alkyl isatins and indoles as acetylcholinesterase and butyrylcholinesterase inhibitors. Article Snippet: Rate vs concentration was fitted to a Lineweaver-Burk plot using Article Title: Amplex red assay, a standardized in vitro protocol to quantify the efficacy of autotaxin inhibitors Article Snippet: |